Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.92K Sell
137
-291
-68% -$17.8K ﹤0.01% 1147
2026
Q1
$27.9K Buy
428
+392
+1,089% +$28.7K ﹤0.01% 724
2025
Q4
$2.9K Sell
36
-118
-77% -$9.49K ﹤0.01% 941
2025
Q3
$12.6K Sell
154
-33
-18% -$2.86K ﹤0.01% 767
2025
Q2
$17.1K Buy
187
+157
+523% +$14K ﹤0.01% 722
2025
Q1
$2.75K Sell
30
-58
-66% -$5.06K ﹤0.01% 967
2024
Q4
$7.49K Buy
88
+26
+42% +$2.28K ﹤0.01% 832
2024
Q3
$5.42K Buy
62
+26
+72% +$2.19K ﹤0.01% 837
2024
Q2
$2.84K Buy
+36
New +$2.96K ﹤0.01% 908

Other funds holding DOX

CVA Family Office's DOX Position: Q2 2026 in Review

CVA Family Office reduced its Amdocs (DOX) stake by 68% in Q2 2026, selling an estimated $17.8K and leaving 137 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

CVA Family Office first reported a position in DOX in Q2 2024 and has held it in 9 quarters since. The position peaked at $27.9K in Q1 2026. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • CVA Family Office held 137 shares of Amdocs worth $6.92K as of Q2 2026.
  • CVA Family Office sold 291 Amdocs shares in Q2 2026, an estimated $17.8K.
  • Amdocs made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1147 holding.
  • CVA Family Office first reported a position in Amdocs in Q2 2024 and has held it in 9 quarters since.
  • CVA Family Office's Amdocs position peaked at $27.9K in Q1 2026.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.